{"id":18426,"date":"2026-06-17T13:10:11","date_gmt":"2026-06-17T13:10:11","guid":{"rendered":"https:\/\/aatworld.com\/?p=18426"},"modified":"2026-06-17T13:10:11","modified_gmt":"2026-06-17T13:10:11","slug":"strong-start-for-taiwans-biotech-sector-in-2026","status":"publish","type":"post","link":"https:\/\/aatworld.com\/ar\/strong-start-for-taiwans-biotech-sector-in-2026\/","title":{"rendered":"Strong Start for Taiwan\u2019s Biotech Sector in 2026"},"content":{"rendered":"<p class=\"has-text-align-left\"><strong>Taiwan\u2019s biotech industry began 2026 with strong momentum, as more than 20 companies reported January revenue growth exceeding 20% year-on-year. Several firms, including Applied BioCode, Synmosa Biopharma Corporation, Vizionfocus Inc., and Vetnostrum Animal Health, achieved record monthly sales.<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>In the contact lens segment, Vizionfocus Inc. reported record January revenue of US$11.5 million, up 43.4% from a year earlier, while Visco Vision Inc. posted nearly 50% growth, supported by demand for premium silicone hydrogel products.<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>In diagnostics, Applied BioCode recorded revenue of US$2.5 million, up 88% year-on-year, driven by strong global demand for respiratory and influenza testing solutions.<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>Meanwhile, PharmaEssentia Corporation reported revenue of US$49.4 million, up 49.8% year-on-year and its second-highest monthly result on record, supported by continued global demand for its flagship therapy, Ropeg.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Taiwan\u2019s biotech industry began 2026 with strong momentum, as more than 20 companies reported January revenue growth exceeding 20% year-on-year. Several firms, including Applied BioCode, Synmosa Biopharma Corporation, Vizionfocus Inc.,&hellip;<\/p>","protected":false},"author":1,"featured_media":18400,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[24,1],"tags":[],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts\/18426"}],"collection":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/comments?post=18426"}],"version-history":[{"count":1,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts\/18426\/revisions"}],"predecessor-version":[{"id":18432,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts\/18426\/revisions\/18432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/media\/18400"}],"wp:attachment":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/media?parent=18426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/categories?post=18426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/tags?post=18426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}